{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:26:06Z","timestamp":1792517166266,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008993","name":"Sveu\u010dili\u0161te u Zagrebu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jpba.2020.113494","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T19:47:23Z","timestamp":1595706443000},"page":"113494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Co-grinding with surfactants as a new approach to enhance in vitro dissolution of praziquantel"],"prefix":"10.1016","volume":"189","author":[{"given":"Alessio","family":"Gaggero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisera","family":"Juri\u0161i\u0107 Dukovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Radi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"\u0160agud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"\u0160kori\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Cin\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Jug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113494_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.actatropica.2017.08.002","article-title":"Schistosomiasis: drugs used and treatment strategies","volume":"176","author":"\u00c2ngelos","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.jpba.2020.113494_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-016-1958-7","article-title":"Efficacy and safety of praziquantel 40 mg\/kg in preschool-aged and school-aged children: a meta-analysis","volume":"10","author":"Zwang","year":"2017","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.jpba.2020.113494_bib0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejps.2016.04.023","article-title":"Molecular and crystal structure of praziquantel. Spectroscopic properties and crystal polymorphism","volume":"92","author":"Borrego-S\u00e1nchez","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2020.113494_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/cts.12601","article-title":"Relative bioavailability of orally dispersible tablet formulations of levo- and racemic praziquantel: two phase I studies","volume":"12","author":"Bagchus","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jpba.2020.113494_bib0025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1017\/S0031182017000014","article-title":"One hundred years of neglect in paediatric schistosomiasis","volume":"144","author":"Wright","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.jpba.2020.113494_bib0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"Olliaro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2020.113494_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.01.033","article-title":"In vitro characterization of some biopharmaceutical properties of praziquantel","volume":"295","author":"Dinora","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpba.2017.01.025","article-title":"Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding","volume":"137","author":"Cugov\u010dan","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113494_bib0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2017.05.053","article-title":"An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: the case of praziquantel","volume":"533","author":"Perissutti","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2018.02.018","article-title":"Milling and comilling Praziquantel at cryogenic and room temperatures: assessment of the process-induced effects on drug properties","volume":"153","author":"Zanolla","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113494_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2018.07.002","article-title":"Identification of degradation products of praziquantel during the mechanochemical activation","volume":"159","author":"\u0160agud","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113494_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpb.2018.01.018","article-title":"A new soluble and bioactive polymorph of praziquantel","volume":"127","author":"Zanolla","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpb.2019.06.029","article-title":"Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model","volume":"142","author":"Lombardo","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jddst.2017.06.010","article-title":"Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs","volume":"41","author":"Chaudhari","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jpba.2020.113494_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10915810802244595","article-title":"Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as use","volume":"27","author":"McLain","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.jpba.2020.113494_bib0080","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2020.113494_bib0085","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1039\/C4PY00039K","article-title":"Pluronic\u00ae block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances","volume":"5","author":"Pitto-Barry","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jpba.2020.113494_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2012.04.076","article-title":"Sucrose esters as natural surfactants in drug delivery systems - a mini-review","volume":"433","author":"Szuts","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpharm.2006.03.028","article-title":"Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel","volume":"318","author":"Passerini","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0100","first-page":"1","article-title":"Spray-dried nanoparticle-loaded pectin microspheres for dexamethasone nasal delivery","author":"Juri\u0161i\u0107 Dukovski","year":"2019","journal-title":"Dry. Technol."},{"key":"10.1016\/j.jpba.2020.113494_bib0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1039\/C1CS15171A","article-title":"Mechanochemistry: opportunities for new and cleaner synthesis","volume":"41","author":"James","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jpba.2020.113494_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.07.011","article-title":"A century of dissolution research: from noyes and whitney to the biopharmaceutics classification system","volume":"321","author":"Dokoumetzidis","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2020.113494_bib0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2013.06.016","article-title":"Drug-excipient compatibility screening-role of thermoanalytical and spectroscopic techniques","volume":"87","author":"Chadha","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113494_bib0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/10837450.2014.996899","article-title":"Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions","volume":"21","author":"Medarevi\u0107","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jpba.2020.113494_bib0125","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2020.113494_bib0130","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1021\/ma00068a010","article-title":"Poly(ethylene oxide)\u2014Poly(propylene oxide)\u2014Poly(ethylene oxide) triblock copolymers in aqueous solution. The influence of relative block size","volume":"26","author":"Mortensen","year":"1993","journal-title":"Macromolecules"},{"key":"10.1016\/j.jpba.2020.113494_bib0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.acthis.2012.01.006","article-title":"MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets","volume":"114","author":"Stockert","year":"2012","journal-title":"Acta Histochem."},{"key":"10.1016\/j.jpba.2020.113494_bib0140","series-title":"Biological Evaluation of Medical Devices - Part 5: Tests for in Vitro Cytotoxicity. ISO 10993-5:2009","author":"ISO 10993-10995","year":"2009"},{"key":"10.1016\/j.jpba.2020.113494_bib0145","series-title":"Curr. Protoc. Toxicol.","article-title":"Caco-2 cells as a model for intestinal absorption","author":"De Angelis","year":"2011"},{"key":"10.1016\/j.jpba.2020.113494_bib0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520313807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520313807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:08:14Z","timestamp":1760000894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520313807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0731708520313807"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113494","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-grinding with surfactants as a new approach to enhance in vitro dissolution of praziquantel","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113494"}}